Obesity and Diabetes
Marcadia Biotech Completes $15 Million Series a Financing
Published in Obesity and Diabetes Week, May 28th, 2007
Marcadia Biotech, a privately held drug development company focused on developing novel biopharmaceutical therapies for diabetes and obesity, announced the completion of a $15 million Series A venture financing. Frazier Healthcare Ventures and founding investor 5AM Ventures co-led this financing round. Joining them in this financing was founding investor Twilight Venture Partners. In connection with this financing, Patrick Heron, general partner of Frazier Healthcare Ventures, joined Marcadia Biotech's board of directors.
Marcadia Biotech announced in November 2006 that it had signed a licensing agreement that gave it the rights to develop and market certain drug...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Obesity
Clock Gene Plays Role in Weight Gain, Study Finds - Obesity and Diabetes
Obesity Increases Risk of Injury on the Job - Obesity and Diabetes
Watch What You Put in That Sippy Cup, Experts Warn - Addiction Medicine
Arche Wellness announced plans today for two new programs - Bariatrics
Only 15 Percent of Bariatric Patients Follow-up With Plastic Surgery, ASPS Report Says - Obesity
California Moms Speak Out in New State Ads to Fight Obesity - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
